Flutic/salmet 232-14mcg 60 Puffs
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only. Continue using it as directed by your doctor or healthcare provider, even if you feel well. Take your dose at the same time every day.
After each use, rinse your mouth with water, but do not swallow the water. Instead, spit it out. If you are using multiple inhaled medications, consult your doctor about which one to use first.
Preparing and Taking Your Dose
Only prepare a dose when you are ready to take it. If you prepare a dose and then close the inhaler without taking it, the medication will be wasted and the inhaler may be damaged. When taking your dose, do not breathe out into the inhaler. Close the inhaler after use.
Important Safety Precautions
Do not take an extra dose, even if you did not taste or feel the powder. Do not disassemble the device or wash it, and do not use it with a spacer. Also, avoid breathing out into the device.
Cleaning and Maintenance
To clean the mouthpiece, gently wipe it with a dry tissue or cloth. Do not wash the mouthpiece or submerge it in water.
Tracking Your Doses
This inhaler has a built-in dose counter to help you keep track of the number of doses remaining. Once the counter reaches "0," or after 1 month from opening the foil pouch, or when the expiration date is reached (whichever comes first), discard the inhaler.
Storage and Disposal
Store the medication at room temperature in a dry place, away from the bathroom. Keep it in the foil pouch until you are ready to use it.
What to Do If You Miss a Dose
If you miss a dose, skip it and return to your regular dosing schedule. Do not take two doses at the same time or take extra doses.
Lifestyle & Tips
- Use regularly as prescribed, even if you feel well.
- Do NOT use for sudden, acute breathing problems; use your rescue inhaler (e.g., albuterol) for those.
- Rinse your mouth with water and spit it out after each dose to prevent oral thrush (yeast infection in the mouth).
- Do not exceed the prescribed dose.
- Keep track of the number of doses used and discard the inhaler after the specified number of actuations or expiration date.
- Avoid triggers that worsen your asthma or COPD (e.g., smoke, allergens, pollutants).
Available Forms & Alternatives
Available Strengths:
- Fluticasone/salmeterol 55/14mcg In
- Flutic/salmeterol 113/14mcg Inh(60)
- Flutic/salmet 232-14mcg 60 Puffs
- Fluticasone/salm Disk 100/50mcg 60s
- Fluticasone/salm Disk 250/50mcg 60s
- Fluticasone/salm Disk 500/50mcg 60s
- Fluticasone/salm 115/21mcg Inh 120s
- Fluticasone/salm Inh 230/21mcg 120s
- Fluticasone/salm Inh 45/21mcg 120s
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat
Signs of a weak adrenal gland: severe nausea or vomiting, severe dizziness or fainting, muscle weakness, extreme fatigue, mood changes, decreased appetite, or weight loss
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Feeling nervous or excitable
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Abnormal burning, numbness, or tingling sensations
Choking
Changes in voice
Seizures
Bone pain
Sleep disturbances
Feeling extremely tired or weak
Vaginal itching or discharge
Weight gain
Mouth irritation or mouth sores
Redness or white patches in the mouth or throat
Important: This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you notice any of the following side effects or any other symptoms that bother you or don't go away, contact your doctor or seek medical attention:
Headache
Upset stomach or vomiting
Throat irritation
* Signs of a common cold
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
- Increased need for your rescue inhaler
- Chest pain or fast/pounding heartbeat
- Severe headache or dizziness
- Tremor or nervousness
- White patches in your mouth or throat (oral thrush)
- Blurred vision or eye pain (rare, long-term)
- Signs of infection (e.g., fever, chills, increased mucus, change in mucus color)
- Signs of allergic reaction (e.g., rash, hives, swelling of face/lips/tongue, difficulty breathing)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any prescription or over-the-counter medications, natural products, or vitamins you are taking that may interact with this medication. Certain medications used to treat HIV, infections, depression, and other conditions should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
If you have a milk allergy.
Please note that this is not an exhaustive list of all potential interactions or health problems that may affect the use of this medication. To ensure your safety, it is crucial to:
Inform your doctor and pharmacist about all medications (prescription or over-the-counter), natural products, and vitamins you are taking, as well as any health problems you have.
Verify that it is safe to take this medication with all your other medications and health conditions.
* Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.
Effectiveness and Monitoring
It may take approximately 1 week to experience the full effects of this medication. If you have diabetes (high blood sugar), consult your doctor, as this medication may increase your blood sugar levels. Immediately contact your doctor if your breathing problems worsen, your rescue inhaler becomes less effective, or you need to use it more frequently.
Dosage and Administration
Do not exceed the recommended dose or use this medication more often than prescribed. Overdosing on this type of medication has been fatal. Consult your doctor if you have any concerns.
Transitioning from Oral Steroids
When switching from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of symptoms such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar. If you experience any of these symptoms, contact your doctor immediately.
In situations where you have a severe injury, undergo surgery, or develop an infection, you may require additional doses of oral steroids to help your body cope with stress. Carry a warning card indicating that you may need extra steroids in these situations.
Long-term Use and Potential Risks
Prolonged use of this medication may increase your risk of developing cataracts or glaucoma. Consult your doctor to discuss this potential risk. It is also recommended that you undergo regular eye exams as advised by your doctor.
Additionally, long-term use may lead to weak bones (osteoporosis). Discuss your risk factors with your doctor and undergo bone density tests as recommended.
Infection Risk and Prevention
You may be more susceptible to infections while taking this medication. To minimize this risk, practice good hygiene by washing your hands frequently and avoiding close contact with people who have infections, colds, or flu.
If you have not had chickenpox or measles before, avoid exposure to these illnesses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed to chickenpox or measles, consult your doctor immediately.
Special Considerations
If you are 65 or older, use this medication with caution, as you may be more prone to side effects.
In children and teenagers, this medication may affect growth in some cases. Regular growth checks may be necessary. Consult your doctor to discuss this potential risk.
If you are pregnant, plan to become pregnant, or are breastfeeding, consult your doctor to weigh the benefits and risks of using this medication.
COPD Considerations
If you have chronic obstructive pulmonary disease (COPD), you are at a higher risk of developing pneumonia. This medication may further increase this risk. Discuss this potential risk with your doctor.
Overdose Information
Overdose Symptoms:
- Excessive beta-adrenergic stimulation (e.g., tachycardia, palpitations, tremor, headache, nausea, hypokalemia, hyperglycemia)
- Signs of hypercorticism (e.g., Cushingoid features, adrenal suppression) with chronic excessive use
What to Do:
Seek immediate medical attention. Treatment is supportive. Call 911 or Poison Control (1-800-222-1222).
Drug Interactions
Contraindicated Interactions
- Concomitant use of other long-acting beta2-adrenergic agonists (LABAs)
Major Interactions
- Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, cobicistat-containing products): May significantly increase systemic exposure to fluticasone and salmeterol, leading to increased risk of systemic corticosteroid effects and cardiovascular effects of salmeterol.
- Beta-blockers (non-cardioselective): May block the bronchodilatory effect of salmeterol and produce severe bronchospasm in patients with asthma or COPD. Cardioselective beta-blockers should be used with caution.
Moderate Interactions
- Diuretics (thiazide or loop): May potentiate hypokalemia and/or ECG changes associated with beta-agonists.
- Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs): May potentiate the cardiovascular effects of salmeterol; use with extreme caution or avoid within 2 weeks of discontinuing MAOIs.
- Other sympathomimetics: May potentiate adverse cardiovascular effects.
Minor Interactions
- Not many specific minor interactions commonly cited for this combination.
Monitoring
Baseline Monitoring
Rationale: To establish baseline lung function and assess disease severity.
Timing: Prior to initiation of therapy
Rationale: To establish baseline symptom control and quality of life.
Timing: Prior to initiation of therapy
Rationale: To check for signs of oral candidiasis (thrush).
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Periodically (e.g., every 3-12 months for stable patients, more frequently for unstable)
Target: Improvement from baseline, maintenance of optimal lung function
Action Threshold: Significant decline from baseline or lack of improvement
Frequency: At each clinical visit (e.g., every 1-6 months)
Target: Reduced frequency and severity of symptoms, minimal rescue inhaler use
Action Threshold: Increased symptoms, increased rescue inhaler use, nocturnal symptoms, exacerbations
Frequency: At each clinical visit
Target: Absence of oral candidiasis
Action Threshold: Presence of white patches or soreness in mouth/throat
Frequency: Regularly (e.g., every 3-6 months)
Target: Normal growth velocity for age
Action Threshold: Growth retardation
Frequency: Periodically, especially in patients with risk factors for osteoporosis
Target: Stable bone density
Action Threshold: Significant bone loss
Frequency: Annually or as clinically indicated for cataracts/glaucoma
Target: Normal intraocular pressure, absence of cataracts
Action Threshold: Increased intraocular pressure, development of cataracts
Symptom Monitoring
- Worsening shortness of breath or wheezing
- Increased need for rescue inhaler (e.g., albuterol)
- Chest tightness or pain
- Palpitations or rapid heart rate
- Tremor or nervousness
- Oral thrush (white patches in mouth/throat)
- Hoarseness or dysphonia
- Blurred vision or eye pain (rare, long-term)
- Signs of systemic corticosteroid effects (e.g., easy bruising, moon face, weight gain, fatigue, weakness)
- Signs of paradoxical bronchospasm (immediate worsening of breathing after inhalation)
Special Patient Groups
Pregnancy
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Fluticasone/salmeterol is Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women.
Trimester-Specific Risks:
Lactation
Caution should be exercised when Fluticasone/Salmeterol is administered to a nursing mother. Both fluticasone and salmeterol are excreted in human milk, but systemic exposure in the infant is expected to be low due to low maternal systemic absorption and poor oral bioavailability.
Pediatric Use
Not indicated for children under 4 years of age. For children 4-11 years, lower strengths are typically used. Monitor growth velocity closely, as inhaled corticosteroids can cause a reduction in growth rate. Monitor for signs of adrenal suppression.
Geriatric Use
No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, elderly patients may be more susceptible to the cardiovascular effects of beta-agonists (e.g., tremor, palpitations, increased blood pressure) and should be monitored.
Clinical Information
Clinical Pearls
- This medication is a controller medication, not a rescue inhaler. Patients should always have a short-acting beta-agonist (SABA) available for acute symptoms.
- Proper inhalation technique is crucial for efficacy. Patients should be instructed and periodically re-evaluated on their technique.
- Rinsing the mouth and spitting after each dose is essential to minimize the risk of oral candidiasis (thrush) and systemic corticosteroid absorption.
- Patients should be advised not to stop therapy abruptly, especially if on high doses, due to the risk of adrenal insufficiency.
- Monitor for signs of pneumonia in COPD patients, as ICS use may increase this risk.
- Regular follow-up is important to assess asthma/COPD control, adjust therapy if needed, and monitor for adverse effects.
Alternative Therapies
- Inhaled Corticosteroid (ICS) monotherapy (e.g., fluticasone propionate, budesonide)
- Long-acting Beta2-Adrenergic Agonist (LABA) monotherapy (not for asthma without ICS)
- Long-acting Muscarinic Antagonist (LAMA) (e.g., tiotropium, umeclidinium) for COPD
- Oral corticosteroids (for severe exacerbations or refractory disease)
- Leukotriene Receptor Antagonists (LTRAs) (e.g., montelukast)
- Biologic therapies (e.g., omalizumab, mepolizumab, dupilumab) for severe asthma